secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001193125-23-122110
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q3 FY2023 revenue +29% to $1.12B; EPS $1.58, non-GAAP $1.68
------------------------------------------------------------------

- Revenue $1,116.9M, up 29% YoY (31% constant currency); diluted EPS $1.58, non-GAAP $1.68.
- Operating income +28% to $300.7M; non-GAAP operating income +27% to $321.2M.
- Gross margin contracted 150 bps to 55.3%; non-GAAP gross margin down 200 bps to 56.1%.
- CEO: full global availability of AirSense 10; ramping AirSense 11; strong mask and SaaS growth.
- Quarterly dividend $0.44/share declared; payable June 15, record May 11.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312523122110/0001193125-23-122110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312523122110/d477335d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-122110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer